Summary: GLP-1 medications typically begin improving blood glucose control within days to two weeks, with full glycaemic benefits developing over 8 to 12 weeks as doses are gradually increased
Omene plans to regularly measure blood samples and track changes in cancer markers, and biopsy participants' abdominal fat cells every six months, to see how those respond, in terms of hormones or inflammation
International expert consensus published in Obesity Pillars (Sievenpiper et al., 2025) recommends prioritizing protein to preserve muscle mass during rapid weight loss, alongside careful attention to fiber, hydration, and micronutrients
Some patients find allowing the medication pen to reach room temperature improves comfort, though this is optional and not specifically required in most product labels
Department of Health and Human Services General Counsel Mike Stuart said he referred Hims & Hers to the Department of Justice for an investigation over potential violations
Glucagon-like peptide-1 or GLP-1 antagonists are, however, a class of medications that mainly manage blood sugar levels in people with Type 2 diabetes
